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Th17Using a mouse model of coxsackievirus B4 (CVB4-V)-induced chronic pancreatitis, we investigated whether
cytokines are involved in the progression of acute disease to chronic inﬂammatory disease. We show that IL-
10 contributed to the development of chronic pancreatitis since acute disease resolved when IL-10 was
absent or when IL-10 signaling was disrupted. We explored the underlying mechanisms by which IL-10
affected disease progression, using a novel approach to assess immunological events occurring in situ.
Multiple markers that deﬁne functional innate immune responses and functional T cell responses were
monitored over the course of CVB4-V infection of wild-type and IL-10 knockout mice, using a multiplex
transcriptional proﬁling approach. We show that high levels of IL-10 early during infection were associated
with delayed innate and T cell responses. Furthermore, high IL-10 production correlated with altered kinetics
of T regulatory responses indicating a disruption in the balance between effector and regulatory T cell
responses.
© 2009 Elsevier Inc. All rights reserved.Introduction
Chronic pancreatitis is a painful and debilitating disease, in which a
progressive, destructive inﬂammatory process destroys the exocrine
pancreas (Mergener and Baillie, 1997; Stevens et al., 2004). Although
gallstones and excessive alcohol consumption are important risk
factors in adults, idiopathic disease represents a fairly high percentage
(22%) of total cases (Lankisch et al., 1996; Lankisch et al., 1991).
Chronic pancreatitis is also a complex disease involving both genetic
predisposition and environmental factors and develops from one
episode of severe acute pancreatitis or from recurrent episodes of
acute disease (Stevens et al., 2004). In order to address fundamental
questions of pathogenesis, we have developed unique mouse models
of coxsackievirus B4-induced acute and chronic pancreatitis that
share many pathological features with the corresponding clinical
disease (Ramsingh, 2008).singh).
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ll rights reserved.Coxsackieviruses are small RNA viruses belonging to the genus
enterovirus of the family Picornaviridae and are capable of inducing a
wide range of diseases (Pallansch and Roos, 2007). Although
infections with the group B coxsackieviruses (CVBs) in humans are
generally asymptomatic, the group B viruses can occasionally cause
inﬂammatory diseases of the pancreas, heart, and central nervous
system. These viruses have been implicated in both acute and chronic
inﬂammatory diseases of the pancreas (pancreatitis) and heart
(myocarditis) (Ramsingh, 2008; Huber and Ramsingh, 2004; Chap-
man and Kim, 2008). Our model system relies on the use of two
variants designated CVB4-P and CVB4-V. Both variants cause acute
infections which result in the development of acute pancreatitis. The
CVB4-V variant induces a severe pancreatitis while the CVB4-P variant
induces a mild pancreatitis. The severity of acute pancreatitis is
determined by the viral genotype (Caggana et al., 1993) and can be
modulated by cytokines such as IL-12 and IFN-γ (Potvin et al., 2003;
Ramsingh et al., 1999). Cytokines can also modulate acute disease
caused by other coxsackieviruses. Cytokines that are beneﬁcial in the
CVB3 model include IL-10 and IFN-γ. Recombinant CVB3 expressing
IL-10 or IFN-γ protects mice against challenge with lethal CVB3
(Henke et al., 2001). While IL-10 and IFN-γ are beneﬁcial during CVB3
infection, TNF-α and IL-1 are deleterious during the acute phase of
infection. Exogenous administration of TNF-α and IL-1 during CVB3
78 R. Gu et al. / Virology 395 (2009) 77–86infection induces myocarditis in otherwise disease resistant mice
(Lane et al., 1992).
While infection with CVB4-P results in a self-limiting disease,
infection with CVB4-V progresses to chronic pancreatitis. Chronic
pancreatitis, in this model, develops in the absence of viral
persistence. The chronic phase of disease is characterized by
prolonged inﬂammation, extensive tissue destruction, and patho-
logical changes in the absence of infectious virus or viral RNA. Since
cytokines are able to modulate CVB-induced acute disease, we
investigated whether cytokines are also involved in the progression
of acute pancreatitis to chronic pancreatitis. This was accomplished
by initially comparing the proﬁles of 20 proteins (measured by
Luminex) in pancreatic tissues from BALB/c mice infected with
either CVB4-P or CVB4-V. The analysis allowed us to identify IL-10
as a potentially pathogenic cytokine during CVB4-V infection of
BALB/c mice. We then showed that IL-10 must be contributing to
the development of chronic inﬂammatory disease after CVB4-V
infection of BALB/c mice, since acute pancreatitis resolved in the
absence of IL-10 or when IL-10 signaling was disrupted. We
explored the underlying mechanisms by which IL-10 affected
disease progression using a novel approach to assess immunological
events occurring in situ during CVB4-V infection of BALB/c and IL-
10 knockout (KO) mice. Multiple markers that deﬁne functional
immune responses, such as TLR activation, Th17 responses, Th1
responses, Th2 responses, and regulatory T cell responses (Treg),
were monitored over the course of CVB4-V infection in the two
mouse strains, using a multiplex transcriptional proﬁling approach.
Results
Identiﬁcation of potentially pathogenic cytokines by multiplex analysis
We undertook a comparative analysis of multiple cytokines in
pancreatic tissues to identify cytokines whose proﬁles differed during
infection with CVB4-P and CVB4-V. Twenty proteins were measured by
Luminex at different times after infectionwith either CVB4-V or CVB4-P
and the data is shown on a separated log scale in Fig. 1A. A distance
metric was calculated to indicate differences in levels of cytokine
expression during CVB4-P and CVB4-V infection. Based on the score of
the distancemetric, the expression patterns of the twenty proteinswere
sorted into four groups (A, B, C, andD). The groupAproteins (IL-4, VEGF,
IFN-γ, IL-13, IL-6, IL-1b, and GM-CSF) had scores of less than 2.5
indicating that expression proﬁles during CVB4-P and CVB4-V infection
were similar. The groupBproteins (FGF,MIG, TNF-α, IP-10, KC, and IL-2)
had scores between 2.5 and 5.0 indicating that expression proﬁles
during CVB4-P and CVB4-V infection were different. The group C
proteins (MIP-1α, MCP-1, IL-17, IL-1a) had scores of between 5.0 and
10.0 indicating that expression proﬁles during CVB4-P and CVB4-V
infection were highly divergent. The most divergent group, group D,
contained three proteins, IL-12, IL-5, and IL-10. Of these three proteins,
the proﬁles for IL-10 were the most different with a distance metric
score of 23.8. IL-10 production during viral infectionwas also plotted on
a linear scale (Fig. 1B). During CVB4-V infection, IL-10 production was
high and sustained. IL-10 was detected as early as 1 day post-infection,
increased to very high levels from 2 to 6 days post-infection (dpi), and
subsequently decreased by 8 dpi. IL-10 production during CVB4-P
infection was transient and relatively low. Peak expression was
observed at 4 dpi and baseline IL-10 levels were restored by 6 dpi.
This study, using male BALB/c mice, identiﬁed IL-10 as a
potentially pathogenic cytokine during CVB4-V-induced disease.
Since both CVB4-V-infected male and female mice progress to chronic
pancreatitis, the prediction is that IL-10 production in infected female
mice would be similar to that observed in infected male mice. IL-10
production in CVB4-V-infected female mice was also high and
sustained (data not shown). Subsequent studies used female mice
since they show less morbidity thanmalemice after CVB4-V infection.IL-10 is pathogenic during CVB4-V infection
The differential production of IL-10 during infection with CVB4-P
or with CVB4-V suggested that IL-10 is pathogenic during CVB4-V
infection. To test this hypothesis, we evaluated the course of
pancreatitis in CVB4-V-infected IL-10 KO (BALB/c genetic back-
ground) mice. Disease severity was monitored by body weight and
by histological assessment of pancreatic tissues since weight loss
and destroyed exocrine tissues are reliable indicators of pancreatitis
in this model. Unlike CVB4-V infection of BALB/c mice, CVB4-V
infection of IL-10 KO mice resulted in an acute pancreatitis which
subsequently resolved (Fig. 2). At 7 dpi, pancreatic tissues from both
IL-10 KO and BALB/c mice showed a generalized inﬂammation,
widespread coagulative necrosis, loss of acinar cells, and acinoduct-
ular metaplasia. Acinar cell necrosis is characterized by pyknotic
nuclei, eosinophilic cytoplasmic content and cellular debris. At 7 dpi,
the main difference between the two strains was a less extensive
loss of acinar cells in the IL-10 KO mice (75% loss) than in the BALB/
c mice (100% loss). By 14 dpi, the exocrine tissues of IL-10 KO mice
were beginning to recover and showed an increase in acini. At this
time point, about 50% of the exocrine tissues in the IL-10 KO mice
appeared normal and contained intact acini. Fat cells appeared to
replace destroyed acini. At the same time point, BALB/c mice
showed no signs of recovery. By 21 dpi, the exocrine tissues of IL-10
KO mice had almost completely recovered and contained abundant
intact acini. Pockets of residual fat cells were observed among
morphologically normal acini. At the same time point, signs of
recovery were notably absent in BALB/c mice. Pathological changes
(coagulative necrosis, generalized inﬂammation, acinoductular
metaplasia) in the pancreas were observed against a background
of ﬁbrosis. Disease severity as determined by histological assessment
of pancreatic tissues was corroborated by measurements of body
weight. During the 3-week follow-up period, CVB4-V-infected IL-10
KO mice, which had less overall pancreatic tissue damage, gained
weight while CVB4-V-infected BALB/c mice, which had extensive
pancreatic tissue damage, lost weight (Fig. 3).
We then validated the data from the IL-10 KO mouse model by
blocking the signaling of IL-10, via its receptor, in CVB4-V-infected
BALB/c mice, by means of an anti-IL-10R antibody. The number of
mice treated with the antibody was small (n=4) because of the
relatively large amount of total antibody (2mg) needed per mouse. As
was observed with CVB4-V-infected IL-10 KO mice, anti-IL-10R-
treated, infected BALB/cmice showed an initial weight loss during the
ﬁrst week of infection followed by weight gain (Fig. 3). Infected mice
treated with a control antibody lost weight during the 3-week follow-
up period. Pancreatic tissues, harvested from anti-IL-10R-treated
CVB4-V-infected BALB/c mice at 21 dpi, showed signs of recovery.
Representative tissue sections are shown in Fig. 2 (panels I and J).
Exocrine pancreatic repair, denoted by the presence of morpholog-
ically intact acini and the absence of characteristic pathological
changes associated with chronic pancreatitis, was evident in anti-IL-
10R-treated mice. The extent of tissue repair in anti-IL-10R-treated
mice was variable. For example, in some samples, 50% of the exocrine
pancreas showed recovery (Fig. 2J) while in other samples, almost
100% of the exocrine pancreas showed recovery (Fig. 2I). Pockets of fat
cells and residual focal inﬂammation were noted within the exocrine
tissues that showed 50% recovery, but these characteristics were
absent in tissues that showed complete recovery. CVB4 infection in
the anti-IL-10R-treated mice was veriﬁed by measurement of anti-
viral antibodies by ELISA. All anti-IL-10R-treatedmice developed anti-
CVB4 antibodies (data not shown).
Although it is widely known that IL-10 deﬁcient mice develop
chronic enterocolitis (Pestka et al., 2004; Kuhn et al., 1993), an
important point is that non-pathogenic enteric bacteria play a key role
in the development of enterocolitis in these mice (Werner et al.,
2007). The IL-10 KO mice used in this study were reared in an SPF
Fig. 1. Identiﬁcation of IL-10 as a potentially pathogenic cytokine during CVB4-V-induced disease. (A) Comparative analysis of 20 protein proﬁles in pancreatic tissues of BALB/cmice
infected with CVB4-P and CVB4-V. The 20 proteins were measured by Luminex at different times after infection and the data is shown on a separated log scale. Three to six organs
were analyzed individually at each time point. A distance metric was calculated to indicate differences in the expression proﬁles. The mean of the squared differences between the
CVB4-P and CVB4-V (mean) values, shown to the right of the plot, is used as a measure of divergence and orders the cytokines from least to most different. The expression proﬁles
were sorted into four groups, A, B, C, and D. Of the 20 proteins, the expression proﬁles for IL-10 during CVB4-P and CVB4-V infection were the most divergent with a distance metric
score of 23.8. CVB4-P: open circles and dashed lines; CVB4-V: ﬁlled circles and solid lines. (B) CVB4-V infection results in high sustained IL-10 production while CVB4-P infection
results in transient low IL-10 production in pancreatic tissues of BALB/c mice. This graph shows the IL-10 data from panel A on a linear scale. The mean value for each group is shown
as a horizontal line bar. Statistical analysis was done using the t-test or the Mann–Whitney U test. Statistically signiﬁcant differences (Pb0.05) between CVB4-V (closed circles) and
CVB4-P (open circles) infections are denoted by asterisks.
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studywhich endedwhenmicewere 3months old. The intestines from
mock-infected mice and from CVB4-V infected mice (35 dpi)
appeared similar and showed characteristic features of healthy,
non-inﬂamed tissues (Fig. 2, panels K and L). The mucosa, sub-
mucosa, andmuscularis externa appeared intact. Villi that project into
the lumen were tightly opposed and showed no signs of damage.
Inﬂammation was notably absent in the small intestine of both mock-
infected- and CVB4-V-infected-IL-10 KO mice.
Overall viral replication is lower and clearance occurs earlier in IL-10 KO
mice
In the current study, viral RNA copy number was used to monitor
viral load in the pancreatic tissues of infectedmice (Fig. 4). The results
of the viral load data for the IL-10 KO mice were conﬁrmed by
monitoring the infectivity of selected samples by plaque assay. Viral
titers peaked between 2 dpi and 4 dpi in both BALB/c and IL-10 KO
mice. Although the kinetics of viral replication was similar in the two
strains of mice, there were two notable differences. First, overall viral
replication was lower in the IL-10 KO mice. Second, viral clearance
was faster in IL-10 KO mice than in BALB/c mice. Infectious virus
(limit of detection is 60 pfu per organ) was not detected at 14 dpi in
IL-10 KO mice. In BALB/c mice, infectious virus is cleared by 21 dpi
(Ramsingh et al., 1999).
Pancreases from CVB4-V-infected BALB/c mice decrease in weight
between 4 and 7 dpi. By 7 dpi, pancreases from CVB4-V infected BALB/
c mice are, on average, one third the weight of those from uninfected
mice or mice undergoing pancreatic repair. If viral load were reported
as copy number per gram of tissue, the difference in viral load
between BALB/c and IL-10 KOmice would be even more pronounced,
but the two main observations would remain unchanged. Of interestis the correlation between viral load (Fig. 4A) and IL-10 production
during CVB4-V infection of BALB/c mice (Fig. 1B). IL-10 production
was highest during the early viral phase of disease (2–6 dpi) when
viral loads were high. A summary of the characteristic features of
CVB4-V infection of BALB/c mice, resulting in the development of
chronic pancreatitis, and of CVB4-V infection of IL-10 KO mice,
resulting in disease resolution, is shown in Fig. 4B.
A question that arises from this study is whether faster viral
clearance is responsible for disease resolution in the IL-10 KO mice.
We have analyzed viral replication in several KO mouse models,
namely, CD4 KO, IL-4 KO, and IFN-γ KO mice (Ramsingh et al., 1999)
and we have shown that viral clearance is faster in the KO strains than
in wild-type BALB/c mice. The main difference noted among the KO
strains is that, whereas the IL-10 KO mice were able to resolve virus-
induced acute inﬂammatory disease, the other KO strains were unable
to resolve acute pancreatitis; instead, they progressed to chronic
inﬂammatory disease similar to that observed in wild-type BALB/c
mice. The combined data indicate that factors other than viral load
and clearance must control disease progression.
Kinetics of gene expression is altered in the presence of high IL-10
The goal of this portion of the studywas to explore the effects of IL-
10 on various immune responses by monitoring the expression of
speciﬁc markers associated with functional responses. Since IL-10 is
generally considered to be an anti-inﬂammatory cytokine that affects
both innate and T cell responses, we examined the expression of
genes associated with innate immune responses (TLRs, CC chemo-
kines, CXC chemokines, and markers expressed by macrophages,
neutrophils, and NK cells) and genes associated with T cell responses
(cytokines, cytokine receptors, transcription factors). The approach
relied on monitoring gene expression using a PCR-based assay in a
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(1 test gene) format. The expression of 45 test genes in pancreatic
tissues was evaluated at various time points after CVB4-V infection of
BALB/c and IL-10 KO mice. The impact of high IL-10 on geneFig. 2. Histopathology of pancreatic tissues after CVB4-V infection of BALB/c and IL-10 KO m
histology, and stained with hematoxylin and eosin. Representative sections of pancreases a
Panels (C) and (E) depict acute inﬂammatory disease in CVB4-V-infected BALB/c mice. Acut
and is characterized by inﬂammation, necrosis, loss of acinar cells and acinoductular metapla
inﬂammation and exocrine tissue destruction after virus has been cleared. Panel (B) shows tis
10 KO mouse which is less severe than that observed in BALB/c mice. Panels (F) and (H)
recovery of the exocrine pancreas by 21 dpi after blocking of IL-10 signaling in an infected
blocking of IL-10 signaling in an infected BALB/c mouse. Panels K (mock-infected) and L (CV
absence of enterocolitis. A, acinus; IL, Islet of Langerhans; TD, tubular/ductular structure;
muscularis externa; IG, intestinal gland (crypts) Original magniﬁcation, ×250.expression proﬁles during the early and late viral phases of disease
was evaluated by comparing expression proﬁles between CVB4-V-
infected BALB/c mice and CVB4-V-infected IL-10 KO mice, from 1 dpi
to 14 dpi.ice. Pancreases were harvested at 7, 14, or 21 dpi and tissues were processed for routine
re shown in panels A to J. Panel (A) shows tissue from a mock-infected BALB/c mouse.
e inﬂammatory disease is deﬁned as the period during which infectious virus is present
sia. Panel (G) depicts chronic inﬂammatory disease which is characterized by prolonged
sue from amock-infected IL-10 KOmouse. Panel (D) depicts acute pancreatitis in the IL-
depict the resolution of acute pancreatitis in IL-10 KO mice. Panel (I) shows complete
BALB/c mouse. Panel (J) shows 50% recovery of the exocrine pancreas by 21 dpi after
B4-V, 35 dpi) are representative sections of intestines from IL-10 KO mice showing the
an, acinar cell necrosis; in, inﬂammatory inﬁltrate; f, fat replacement; v, villus; ME,
Fig. 3. IL-10 KO mice and anti-IL-10R-treated BALB/c mice gain weight during CVB4-V
infection. For IL-10 KO mice (●) and untreated BALB/c mice (○), each datum
represents one mouse. The average value at each time point is shown as a horizontal
line bar. Robust regression analysis was used to estimate parabolic changes in weight
values and corresponding 95% conﬁdence intervals. The resulting intervals suggest that
changes in body weight of infected BALB/c mice and infected IL-10 KO mice diverge as
early as 4 dpi. For CVB4-V-infected BALB/c mice treated with the anti-IL-10R antibody
(□) or a control antibody (△), averaged values are shown.
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(a) all 45 test genes were expressed at higher levels in infected BALB/
c mice than in infected IL-10 KO mice, (b) the pattern of geneFig. 4. Overall viral replication is lower and viral clearance is faster in CVB4-V-infected IL-10 K
at each time point for each mouse strain) was monitored by RT-PCR and copy number was de
are shown. The limit of detection of the assay is 1.2×103 RNA copies per pancreas. Statistic
which signiﬁcant differences (Pb0.05) in viral load exist between BALB/c (closed squares) a
plaque assay at 14 dpi. (B) Virological and pathological hallmarks of CVB4-V infection of BA
with a longer acute inﬂammatory disease of the pancreas characterized by the presence o
pancreatitis progresses to chronic pancreatitis in the absence of viral persistence and is chara
CVB4-V infection of IL-10 KOmice is associated with a shorter acute inﬂammatory disease ch
tissue destruction. Acute disease does not progress to chronic disease and, instead, resolvesexpression, monophasic or biphasic, was similar between the two
strains of mice, and (c) the kinetics of peak expression of some genes
differed between the two strains of mice. Higher expression of
immune markers probably reﬂects the increased viral replication
observed in CVB4-V-infected BALB/c mice. The magnitude of gene
expression in CVB4-V-infected IL-10 KO mice is probably under-
estimated in this study. The accumulation of mRNA at a given time
point reﬂects the dynamic balance between transcriptional control
and mRNA stability. In addition, steady-state levels of mRNAs are
inﬂuenced by the events occurring in the affected organ, such as
inﬂammation and tissue repair of the exocrine pancreas. During
CVB4-V infection of BALB/c mice, the mRNA contribution from the
pancreas must have remained constant over the 2-week period of
study, given that the exocrine tissues are completely destroyed 2 days
after infection. During CVB4-V infection of IL-10 KO mice, the mRNA
contribution from the pancreas changed because of decreased tissue
damage (75% in the KO versus 100% in BALB/c mice at 7 dpi) and
tissue repair (50% tissue recovery at 14 dpi). The temporal change in
mRNA contribution from the pancreas in infected IL-10 KO mice
affects the magnitude of expression proﬁles. As a result, peak
expression of immune markers during the early viral phase of disease
in the IL-10 KOmice is probably underestimated by roughly 25%while
peak expression during the late viral phase of disease is probably
underestimated by roughly 50%.
Since the kinetics of peak expression of some genes differed
between infected BALB/c and IL-10 KO mice, a clustering algorithm
was used to identify groups of genes with similar kinetic proﬁles. The
analysis identiﬁed four groups of genes (Table 1) which were also
sorted according to function (Table 2). Group 1 contains 17 genes
whose peak expression occurred at the same time (4 dpi) in the two
strains of mice. The group 1 genes consist of markers of TLR, Th17 andOmice than in CVB4-V-infected BALB/c mice. (A) Viral RNA in pancreatic tissues (n=5
termined using the absolute quantiﬁcation assay. Mean values and standard deviations
al analysis was done using the Mann–Whitney U test. Asterisks indicate time points at
nd IL-10 KO (open squares) mice. #; indicates that infectious virus was not detected by
LB/c (top) and IL-10 KO (bottom) mice. CVB4-V infection of BALB/c mice is associated
f infectious virus, an inﬂammatory inﬁltrate, and extensive tissue destruction. Acute
cterized by prolonged inﬂammation and extensive destruction of the exocrine pancreas.
aracterized by the presence of infectious virus, an inﬂammatory inﬁltrate, andmoderate
after viral clearance.
Table 1
Kinetics of peak mRNA expression of immune-related genes differ between CVB4-V-
infected BALB/c mice and CVB4-V-infected IL-10 KO mice.
Gene group No. genes Time of highest expression
IL-10 KO BALB/c
1 17 4 dpi 4 dpi
2 22 4 dpi 6 dpi
3 4 4 dpi 2 dpi
4 2 10 dpi 6 dpi
Table 2
Functional sorting of the genes within the four kinetically distinct groups observed in
CVB4-V-infected BALB/c mice.
Functional
grouping
Gene group
1 2 3 4
TLR tlr2, tlr3, tlr5 tlr4, tlr7, tlr9, myd88
Th17 csf2, ccl4, il6st,
il17rb, tgfb1,
tnfa, il22
cxcl2, il8ra, il17ra, il6ra,
rorgt
csf3, cxcl1,
il6, il8rb
Th1 ccl2, ccl3, ccr1, ccr3,
cxcl10, ebi3, socs5
ccl5, ccr2, ccr5, cxcl9,
cxcl11, cxcr3, ifng, ifngr1,
nos2, tbet
Th2 gata3, tmed1
Treg foxp3
Other socs3 il13
Each functional group contains genes whose expression is associated with a speciﬁc
response. For example, the TLR group contains genes encoding Toll-like receptors and
adaptor molecules. Each of the remaining groups contains genes that are speciﬁc for a T
cell subset (such as transcription factors, in italics) and genes that function in the
activation and differentiation of speciﬁc T cell subsets and in the recruitment of effector
cells (ex. neutrophils for Th17; macrophages and T cells for Th1).
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delayed in BALB/cmice. The group 2 genes consist of markers of TLR,
Th17, Th1, and Th2 responses. Group 3 contains 4 genes whose peak
expression is earlier in BALB/c mice than in IL-10 KO mice. The
group 3 genes consist of markers of Th17 responses. Group 4
contains 2 genes whose peak expression is earlier in BALB/c mice
than in IL-10 KO mice. The two genes, foxp3 and il13, are markers of
regulatory responses. Representative expression proﬁles of genes in
each of the four groups are depicted in Fig. 5. To determine if the
RNA expression proﬁles correlated with protein proﬁles, we
analyzed representative cytokines and chemokines in CVB4-V
infected BALB/c mice. Representatives of the group 1 genes, TNF-
α and CXCL10, yielded protein proﬁles that correlated with their
respective RNA proﬁles, peaking at 4 dpi (Fig. 5). A representative of
the group 2 genes, CXCL9, also yielded a protein proﬁle that
correlated with the RNA proﬁle, peaking at 6 dpi. A representative of
the group 3 genes, IL-6, also yielded a protein proﬁle that correlated
with the RNA proﬁle, peaking at 2 dpi. The overall data show that
high IL-10 is associated with delays in maximal expression of
markers for inﬂammatory and T cell responses during CVB4-V
infection of BALB/c mice. In addition, high IL-10 is associated with
alterations in the kinetics of regulatory responses.
Discussion
The present study shows, for the ﬁrst time, that IL-10 must play a
critical role in the development of chronic inﬂammatory disease in the
pancreas, subsequent to CVB4-V infection, since the absence of IL-10
or disruption of signaling via IL-10 resulted in the resolution of acute
disease. We also show that high levels of IL-10 early during CVB4-V
infection were associated with delayed innate and T cell responses.
Furthermore, high IL-10 production correlated with altered kinetics of
Treg responses indicating a disruption in the balance between effector
T cell responses and regulatory T cell responses.
A key question in the study of CVB4-V-induced chronic
pancreatitis is whether viral persistence contributes to the devel-
opment of chronic disease. Viral persistence may be due to
continuous production of low levels of infectious virus or to the
prolonged presence of viral RNA, capable of generating low levels of
viral proteins that continue to stimulate T cells. The question is
relevant in light of studies with certain strains of LCMV that cause
long-term persistence with viremia. When the IL-10 pathway is
disrupted, LCMV strains that would normally establish persistence
are cleared from blood and organs of infected mice (Brooks et al.,
2006; Ejrnaes et al., 2006). The evidence suggesting that viral
persistence does not contribute to the development of chronic
pancreatitis in our model is as follows. Firstly, ampliﬁed VP1
sequences in pancreatic tissues of CVB4-V-infected mice are not
detected after infectious virus is cleared (A. Ramsingh, unpublished
observations). Secondly, the target cells for CVB4-V in the pancreas
are the acinar cells which are completely destroyed by 14 days after
infection (Ostrowski et al., 2004), resulting in the absence of a
reservoir in which CVB4-V can persist. Finally, disruption of IL-10
signaling in CVB4-V-infected BALB/c mice prevented the develop-
ment of chronic disease. The combined data indicate that, in thismodel, IL-10, and not viral persistence, is critical in the development
of chronic pancreatitis.
The ﬁnding that IL-10 plays a critical role in the development of
chronic inﬂammatory disease in the pancreas is surprising, given that
IL-10 is an anti-inﬂammatory cytokine that regulates innate and
adaptive Th1 and Th2 responses (Pestka et al., 2004; Couper et al.,
2008). IL-10 plays a key immunoregulatory role during infections: this
cytokine functions to suppress proinﬂammatory responses during an
infection to reduce immunopathology. Ablation of IL-10 signaling
generally results in severe, often fatal immunopathology in several
infections, including Toxoplasma gondii (Gazzinelli et al., 1996;Wilson
et al., 2005), malaria (Li et al., 1999, 2003), and Trypanosoma cruzi
(Hunter et al., 1997). The timing of the production of IL-10 must be
well-controlled becausemistimed and/or excessive production of this
cytokine will suppress the very proinﬂammatory responses that are
needed to clear the pathogen (Couper et al., 2008). Mistimed and/or
excessive IL-10 production can lead to a pathogen escaping immune
control and subsequent fulminant and fatal or chronic non-healing
infection. One such example is Mycobacterium avium infection of
BALB/c mice; this infection is associated with very early IL-10
production and failure to control the infection (Roque et al., 2007).
A relevant issue is whether early high production of IL-10 is the
consequence of a high pathogen burden or whether IL-10 production
is a function of pathogen virulence. If IL-10 production were the
consequence of a high pathogen burden, then the kinetics of IL-10
production should correlate with the kinetics of viral replication,
independently of pathogen virulence. We have shown that the
kinetics of replication for both CVB4-P and CVB4-V are similar
(Ostrowski et al., 2004; Ramsingh et al., 1997, 1999). While the
kinetics of IL-10 production during CVB4-V infection correlates with
the kinetics of viral replication, the kinetics of IL-10 production during
CVB4-P infection does not correlate with the kinetics of viral
replication. In our model, IL-10 production appears to be a function
of pathogen virulence, with early high production of this cytokine
during infection with the virulent CVB4-V variant and low transient
production during infection with the less virulent CVB4-P variant.
Our study used a novel approach to assess immunological events
occurring in situ. Multiple markers that deﬁne functional immune
responses, such as TLR activation, Th17 responses, Th1 responses, Th2
responses, and Treg responses, were monitored over the course of
infection by means of a multiplex transcriptional proﬁling approach.
An important issue is whether conclusions concerning basic immu-
nological mechanisms can be made based on this approach. Two
pieces of evidence suggest that a multiplex transcriptional proﬁling
approach is useful for gaining insight into immunological events
Fig. 5. Representative expression proﬁles of immune-related genes depicting peak mRNA expression in CVB4-V-infected BALB/c mice relative to CVB4-V-infected IL-10 KO mice.
Closed arrows depict the time of peak expression in BALB/c mice and open arrows depict the time of peak expression in IL-10 KOmice. Gene expression was monitored in pancreatic
tissues at different times after infection using the TaqMan Gene Expression Assay. Three to ﬁve organs were analyzed at each time point for BALB/cmice (closed circles) and for IL-10
KO mice (open circles). The change in gene expression is represented as a fold-change. Fold change in RNA expression was calculated using CVB4-V-infected BALB/c mice at 2 dpi.
Because the relative expression of nos2 and foxp3 in IL-10 KO mice is low when the reference group is CVB4-V-infected BALB/c mice at 2 dpi, the expression of these two genes was
also calculated using CVB4-V-infected IL-10 KO mice at 2 dpi as the reference group (▴ and dashed grey lines). Four kinetically distinct groups (1–4) of genes were observed in
infected BALB/c mice. Group #1 genes peaked at 4 dpi while group #2 genes peaked at 6 dpi and group #3 genes peaked at 2 dpi. Regulatory genes in group #4 peaked aberrantly
early. To determine if RNA expression proﬁles correlated with protein proﬁles, representative proteins (TNF-α, CXCL10, CXCL9, and IL-6) were measured by Luminex and protein
proﬁles are indicated by closed squares and dashed lines.
83R. Gu et al. / Virology 395 (2009) 77–86occurring in situ. Firstly, we showed that representative RNA
expression proﬁles correlate with protein proﬁles of cytokines and
chemokines. Secondly, published data from a variety of experimental
approaches (KO mouse models, phenotypic analysis of inﬂammatory
inﬁltrates, cytokine treatment, in vivo depletion of cytokines, and
in vivo depletion of T cell subsets) show that Th1 responses, while
beneﬁcial during the viral phase of disease, contribute to diseaseprogression (Ramsingh et al., 1999; Potvin et al., 2003; Ramsingh
et al., 1997). The current study also identiﬁed markers of Th1
responses as being important in the disease process; therebyproviding
support for the idea that amultiplex transcriptional proﬁling approach
is informative for assessing immunological events occurring in situ.
A key ﬁnding of the study is that the production of high IL-10
during CVB4-V infection is associated with a delay in the peak
84 R. Gu et al. / Virology 395 (2009) 77–86expression of several genes that function in innate and adaptive
immune responses. Group 2 genes consisting of markers of TLR
activation, Th17 responses, Th1 responses, and Th2 responses
exhibited delayed maximal expression in infected BALB/c mice
when compared to those in infected IL-10 KOmice (Table 1). Markers
of TLR activation include tlr4, tlr7, tlr9, and myd88. TLR4 is a surface
receptor that binds LPS while TLR7 and TLR9 are endosomal receptors
that bind ssRNA and CpG DNA, respectively (Sabroe et al., 2008;
Thompson and Iwasaki, 2008). All three TLRs signal via the adaptor
MyD88. TLR signaling via MyD88 can activate NF-κB, leading to a
proinﬂammatory response due to transcription of numerous genes,
including those encoding cytokines and chemokines (Liu and Malik,
2006). While TLR4 and TLR7 have been identiﬁed by others (Huber,
2008; Triantaﬁlou et al., 2005) as initiating the inﬂammatory response
during CVB infection, the present report is the ﬁrst to link TLR9 to CVB
infection. Studies of CVB3 infection of cardiac cells show that TLR8,
and to a lesser extent TLR7, initiate the inﬂammatory response via
recognition of ssRNA (Triantaﬁlou et al., 2005). TLR4 can also trigger a
low-level inﬂammatory response, indicating that the CVB3 virion
itself is recognized by the cell surface receptor (Huber, 2008). A delay
in TLR activation during CVB4-V infection of BALB/c mice is expected
to delay proinﬂammatory responses needed to contain viral infection.
Consequences of delayed proinﬂammatory responses are higher viral
loads and delayed viral clearance, both of which are observed during
CVB4-V infection of BALB/c mice.
Markers of various T cell responses, including cytokines, chemo-
kines, and receptors, also exhibited delayed maximal expression
during CVB4-V infection of BALB/c mice. In addition, genes encoding
transcription factors for speciﬁc T cell subsets, such as RORγt (Th17),
T-bet (Th1), and GATA-3 (Th2), displayed delays in peak expression.
The data support the conclusion that proinﬂammatory and T cell
responses are delayed in the presence of high IL-10 during CVB4-V
infection of BALB/c mice. Given that IL-10 production is a function of
pathogen virulence in this model, the implication is that the virulent
CVB4-V variant induces early high production of IL-10, and this
production delays proinﬂammatory and T cell responses, thereby
providing the opportunity for the virus, early in the infection cycle, to
replicate rapidly and spread throughout the exocrine pancreas.
Generalized infection of the pancreas yields more severe tissue injury
and heightened immune responses than limited focal infection and
leads to extensive tissue destruction and the development of severe
acute pancreatitis. In the absence of IL-10, proinﬂammatory and T cell
responses were not delayed, virus replication was decreased, and less
tissue damage was observed during the acute phase of disease.
Another ﬁnding of the present study is that high IL-10 production
correlated with altered kinetics of Treg responses, indicating a
disruption in the balance between effector and regulatory T cell
responses. Since CVB4-V infection of IL-10 KO mice resulted in viral
clearance, tissue repair, and the absence of immunopathology, the
implication is that infected IL-10 KO mice mounted effective, well-
regulated immune responses against the infection. The assumption is
that responses that peaked during the early viral phase of disease (ﬁrst
week after infection) are indicative of effector responses while
responses that peaked during the late viral phase of disease (second
week after infection) are indicative of regulatory responses. In infected
IL-10 KO mice, genes that displayed maximal expression early in
infection (4 dpi) were those that are indicative of TLR, Th17, Th1, and
Th2 effector responses. Two genes, foxp3 and il13, showed maximal
expression later in infection (10 dpi). Foxp3 is a key transcription
factor of Treg cells (Shevach, 2009; Zhou et al., 2009; Curotto de Lafaille
and Lafaille, 2009) while IL-13 can induce the development of CD25+
Treg cells (Skapenko et al., 2005) and of alternatively activated
macrophages (Martinez et al., 2009). Alternatively activated macro-
phages have a regulatory function since they suppress Th1 responses
and favor tissue repair. High expressionof foxp3 and il13 in infected IL-
10 KOmice correlated with diminishing effector responses. Unlike theﬁndings in IL-10 KOmice, expression of both foxp3 and il13 in infected
BALB/cmicewasmaximal early in infection (6 dpi) and remained high
during the late viral phase of disease. High expression of foxp3 and il13
in infected BALB/c mice did not correlate with diminishing effector
responses. Thedata suggest that the dynamic balance betweeneffector
T cell responses and regulatory T cell responses is preserved in infected
IL-10 KOmice and is disrupted in infected BALB/c mice. Although one
mechanism by which regulatory T cells exert their suppressive
function is the production of IL-10, the expression proﬁles of IL-10
(Fig. 1) and foxp3 (Fig. 5) in infectedBALB/cmice do not correlatewith
one another. Our working hypothesis is that the combination of a
virulent lytic virus and high early IL-10 production in pancreatic
tissues causes severe acute pancreatitis and a cytokine environment
that favors disease progression. The progression of acute disease to
chronic disease is due to disruption in the balance between effector
and regulatory T cell responses leading to the failure of regulatory T
cells to inhibit effector T cells. If this is true for clinical chronic
pancreatitis, then immunomodulatory approaches may be useful in
halting disease progression. Ongoing studies of our model system are
exploring immunomodulatory strategies to restore the balance
between effector and regulatory T cell responses during the chronic
phase of disease to determinewhether damagedpancreatic tissues can
be restored.
Materials and methods
Cells, viruses, and mouse strains
CVB4-V is a viral variant that was selected after multiple passages
of the JVB strain of CVB4 in mouse pancreas (Ramsingh et al., 1989).
Unlike the prototypical JVB strain of CVB4 which causes a transient
acute pancreatitis, CVB4-V causes a severe acute pancreatitis that can
progress to chronic pancreatitis. A large-scale stock of plaque-puriﬁed
virus was grown in LLC-MK2(D) cells and viral infectivity was
measured by plaque assay. Two strains of mice were used in this
study. BALB/c mice, purchased from The Jackson Laboratory (Bar
Harbor, ME), were housed in a Speciﬁc Pathogen Free (SPF) facility at
theWadsworth Center (Albany, NY). IL-10 KO (IL-10−/−) mice on the
C57BL/6 genetic background were bred onto the BALB/c background
by Dr. William Lee (Wadsworth Center) for 11 generations. After 10
generations of traditional backcrossing, the recipient genome is 99.9%
(www.criver.com). Thus, after 11 generations, the IL-10 KO mice have
greater than 99.9% of the BALB/c genetic background. The IL-10 KO
(BALB/c) strain was maintained in a SPF facility by Dr. David
Lawrence (Wadsworth Center). Breeder pairs were kindly provided
by Dr. Lawrence and IL-10 KO mice were bred and maintained in an
SPF environment.
Five-to-six week old mice (15–18 g) were used in the study. Mice
were infected intraperitoneally with CVB4-V and were allowed to eat
and drink ad libitum. Because male mice develop a more severe acute
pancreatitis than femalemice (Ramsingh et al., 1999), malemicewere
infected with 103 pfu of virus while female mice were given 104 pfu of
virus. Mice were sacriﬁced at various time points after infection and
organs were removed. Pancreatic tissues were ﬁxed in Bouin's
solution (Sigma-Aldrich, St. Louis, MO), processed for routine
histology, and sections were stained with hematoxylin and eosin.
All animal procedures were approved by the Institutional Animal Care
and Use Committee (IACUC) of the Wadsworth Center.
Disruption of IL-10 signaling by treatment with anti-IL-10R antibodies
Six-week old BALB/c mice (n=4) were infected intraperitoneally
with 104 pfu of CVB4-V. Infected mice were injected intraperitoneally
with a rat anti-mouse IL-10R antibody (1B1.3a; IgG1), kindly provided
by Dr. Stephen Smiley (Trudeau Institute), on the day of infection
(0.5 mg/mouse) and every 3 days (0.25 mg/mouse) thereafter, until
85R. Gu et al. / Virology 395 (2009) 77–8618 dpi. CVB4-V-infected mice in the control group were treated with
an isotype control antibody. Disease severity was determined from
body weight measurements and histological assessment of pancreatic
tissues. Body weight measurements were done every other day. Mice
were sacriﬁced 21 dpi and pancreatic tissues were processed for
routine histology as described above.
Isolation of pancreatic RNA
Pancreatic tissues, harvested at various time points after infection,
were frozen immediately on dry ice and placed in TRI reagent
(Molecular Research Center, Inc. Cincinnati, OH) which combines
phenol and guanidine thiocyanate in a mono-phase solution to inhibit
RNase activity. Tissues were homogenized in a mini-beater (Biospec
Products, Bartlesville, OK) using 1 mm Zirconia beads (Biospec
Products). After a clarifying spin at 10,000×g for 10 min at 4 °C, the
homogenate was separated into aqueous and organic phases by the
addition of 1-bromo-3-chloropropane (BCP) (Molecular Research
Center) and centrifugation. RNA was precipitated from the aqueous
phase by the addition of isopropanol, washed with ethanol, and
resuspended in water. Residual DNA was digested with DNase
(Promega, Madison, WI) and puriﬁed RNA was obtained using an
RNeasy column (Qiagen, Valencia, CA).
Measurement of viral load in pancreatic tissues
Viral RNA in pancreatic tissues was monitored by RT-PCR using a
TaqMan Gene Expression Assay, and copy number was determined by
the absolute quantiﬁcation assay. A standard curve was generated
using viral RNA transcribed from a linearized plasmid DNA containing
the full-length CVB4-V sequence. After treatment with DNase 1 and
proteinase K, the concentration of viral RNA was measured with a
NanoDrop Spectrophotometer (Thermo Scientiﬁc, Wilmington, DE)
and viral copy number was calculated. In vitro transcribed viral RNA
(3 ug) was reverse transcribed using Moloney murine leukemia virus
reverse transcriptase (M-MLV RT) (Invitrogen, Carlsbad, CA) and
random hexamers, in a total volume of 25 μl. Serial dilutions of viral
cDNAs were prepared to generate the standard curve. Total pancreatic
RNA (3 μg) from test samples was reverse transcribed under the same
conditions as were used for the viral RNA standard. Serially diluted
viral cDNA standards and pancreatic test cDNA samples were loaded
onto a single 96-well plate. A region of the VP1 sequence was
ampliﬁed with two unlabeled PCR primers (5′-TGAGCAAATCC-
CAGCTCTGA, 5′-TGGATCCACCTGGGAAGTATG) and a FAM-dye-la-
beled TaqMan probe (5′-AGCTGTGGAGACTGG) in an Applied
Biosystems 7500 Real-Time PCR System (Applied Biosystems, Foster
City, CA) using the Absolute Quantiﬁcation software. A standard curve
(threshold cycle number (Ct) vs viral copy number), generated from
the serially diluted viral cDNAs, was used to determine the viral copy
number in the pancreatic test samples.
Viral load is shown as copy number per pancreas instead of per gram
tissue because the isolation of intact pancreatic RNA requires rapid
harvesting and processing in order to overcome the inherent problem
of high RNase levels in the pancreas. Pancreases that are processed for
RNA isolation are notweighedbecause anydelay in processing activates
pancreatic RNases, resulting in degraded RNA samples.
Gene expression in pancreatic tissues of CVB4-V-infected mice
Gene expression was quantiﬁed using the TaqMan Gene Expres-
sion Assay in a two-step RT-PCR and a TaqMan Low Density Array
(LDA), a 384-well micro ﬂuidic card, preloaded with appropriate PCR
primers and probes (Applied Biosystems). Total pancreatic RNA was
reverse-transcribed with M-MLV RT and random hexamers in a
reaction volume of 25 μl using standard conditions. Brieﬂy, random
hexamers (Invitrogen, Carlsbad, CA) were added to 3 μg total RNAwhich was denatured at 90 °C. Samples were frozen immediately on
dry ice and then thawed slowly on ice. After the addition of a cocktail
containing dNTPs (1 mM) (Roche, Basel, Switzerland), RNasin
(Promega, Madison, WI), DTT (0.1 M), and M-MLV RT, the reaction
was incubated at 37 °C, heat-inactivated at 70 °C, and cDNAs were
stored at −80 °C. 100 ng of cDNA were mixed with Taqman Fast
Universal PCR Master Mix (Applied Biosystems) to a ﬁnal 1×
concentration and approximately 2 ng of the cDNA solution were
applied to each of 48 wells in the LDA card. PCR ampliﬁcation was
carried out in an Applied Biosystems 7900HT Fast Real-Time PCR
System. Eight pancreatic samples were analyzed simultaneously for
the expression of 47 genes and 18S ribosomal RNA in one 384-well
LDA card. The LDA card contained three possible controls, 18S RNA,
Egf, and Slc2a2/Glut-2. The expression of Egf remained unchanged
during CVB4-V infection while the expression of both 18S RNA and
Slc2a2 varied over the course of the infection. As a result, expression
of test genes was normalized to that of Egf. The expression of one
additional gene, RORγt, not present on the LDA card, was quantiﬁed
using the TaqMan Gene Expression Assay in a two-step RT-PCR in a
single-tube format, with the Applied Biosystems 7500 Real-Time PCR
System. The expression of RORγt was again normalized to that of Egf.
Analysis of gene expression data
The study focused on pancreatic gene expression at multiple time
points in two treatment groups, CVB4-V-infected BALB/c mice and
CVB4-V-infected IL-10 KO mice. Three to ﬁve mice per strain were
analyzed at each time point and gene expression was quantiﬁed by a
comparative Ct method (Applied Biosystems). The Ct value of each
test gene in each organwas normalized to that of the control gene, Egf.
The resulting [delta] Ct values for samples from each time point were
then averaged. Since the goal of the study was to evaluate the
magnitude of gene expression over time within a single treatment
group and between treatment groups, a reference group was needed.
The reference group chosen for all except one test gene was CVB4-V-
infected BALB/c mice, 2 dpi, because gene expression was very low or
undetectable prior to this time point. For the one other test gene,
RORγt, the reference group was CVB4-V-infected BALB/c mice at 4
dpi. The change in gene expression is represented as a fold-change
which was calculated by determining 2−ddCt(ddCt=averaged [delta]
Ct (speciﬁc time point)−averaged [delta]Ct BALB/c 2dpi). As a result, for all
genes except RORγt, the relative expression in CVB4-V-infected
BALB/c mice at 2 dpi is 1. For RORγt, the relative expression in CVB4-
V-infected BALB/c mice at 4 dpi is 1.
Protein production in pancreatic tissues of CVB4-V infected mice
Organs, harvested at various time points after infection, were
frozen immediately on dry ice and placed in 1 ml of lysis buffer
containing protease inhibitors (50 mM Tris, 150 mM NaCl, 2 mM
EDTA, 1% NP40, 30 μMPMSF, 420 μM leupeptin, 0.02% aprotinin, 3 mM
NaN3). Organs were homogenized in a mini-beater (Biospec Products,
Bartlesville, OK) using 1 mm Zirconia beads (Biospec Products). After
a clarifying spin at 10,000×g for 10 min at 4 °C, the supernatants were
stored frozen at −80 °C. Cytokines and chemokines in pancreatic
homogenates were measured using a multiplex bead-based assay,
Luminex (Invitrogen), according to the manufacturer's protocol.
Three to six organs were analyzed individually at each time point.
Statistical analysis
For some genes, the kinetics of peak mRNA expression differed
between CVB4-V-infected BALB/c mice and CVB4-V-infected IL-10 KO
mice. The variable nature of the kinetics of gene expression was
captured by clustering cytokines on an arbitrary weighting of three
characteristics of the proﬁle during the early viral phase of disease (1–
86 R. Gu et al. / Virology 395 (2009) 77–868 dpi): time of peak occurrence (P, 10%); percent area of the peak (A,
20%); and shift in day of maximal response (S, 70%). The results are
insensitive to changes in the weightings. The resulting cytokine scores
(0.1P+0.2A+0.7S) were then subjected to an agglomerative
hierarchical clustering algorithm (Kaufman and Rousseeuw, 1990)
using a Euclidean distance metric between the scores. The clustering
analysis allowed us to identify four kinetically distinct groups of genes
in infected BALB/c mice (Table 1).
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